Outlook Therapeutics Inc. buy BiotechBee
Start price
12.06.24
/
50%
€7.30
Target price
28.02.26
€10.00
Performance (%)
-80.96%
End price
14.12.24
€1.39
Summary
This prediction ended on 14.12.24 with a price of €1.39. The BUY prediction by BiotechBee for Outlook Therapeutics Inc. performed very badly with a performance of -80.96%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Outlook Therapeutics Inc. | -15.214% | -15.214% | -73.264% |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % |
According to BiotechBee what are the pros and cons of Outlook Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Outlook Therapeutics Inc. diskutieren
Buy mit Kursziel 10,0